Researcher

Associate Professor Orin Chisholm

Field of Research (FoR)

SEO tags

Biography

Orin Chisholm is the Program Director and Associate Professor in Pharmaceutical Medicine in the School of Medical Sciences at UNSW. She is a Senior Fellow of the Higher Education Academy.

In 2017 she received the Award for Excellence in Regulatory Affairs Education from the international Organisation for Professionals in Regulatory Affairs (TOPRA).

TOPRA award banner

 

 

 

 

She has extensive experience in the pharmaceutical industry, which has equipped...view more

Orin Chisholm is the Program Director and Associate Professor in Pharmaceutical Medicine in the School of Medical Sciences at UNSW. She is a Senior Fellow of the Higher Education Academy.

In 2017 she received the Award for Excellence in Regulatory Affairs Education from the international Organisation for Professionals in Regulatory Affairs (TOPRA).

TOPRA award banner

 

 

 

 

She has extensive experience in the pharmaceutical industry, which has equipped her to embed practical, current and innovative education in pharmaceutical medicine in her role as program director. She has significant expertise in regulatory affairs in both large multinational pharmaceutical and small biotechnology companies in Australia.   She has particular success in the registration of biotechnology products for oncology indications.  She has contributed her expertise in global regulatory affairs to an important textbook on international regulatory affairs published by the Regulatory Affairs Professional Society (RAPS).

Orin was a member of the Gene Technology Technical Advisory Committee (GTTAC) from 2017-2020. In this role, she provided advice to the Gene Technology Regulator, the federal Office of the Gene Technology Regulator (OGTRand the Legislative Governance Forum on Gene Technology on all matters relating to gene technology, genetically-modified organisms (GMOs) and genetically modified (GM) products, including applications made to the Regulator under the Gene Technology Act, the biosafety aspects of gene technology and the need for and content of policy principles, guidelines, codes of practice and technical and procedural guidelines in relation to GMOs and GM products in Australia.

Orin is an adjunct faculty member, Edson College of Nursing and Health Innovation, Arizona State University.

Orin also has a strong academic background in the molecular biology of haemopoiesis and oncology and she has teaching qualifications in higher education. In 2016, she received a Faculty of Medicine teaching award for outstanding contributions to student learning. 

Orin is a member of the Australia-wide CRITERIA (Clinical-Research-Industry’s-Talent-Expansion-Retention-Investment & Advancement) Consortium, led by ARCS Ltd., which has received $250,000 funding from MTPConnect for Building clinical trial capability and capacity to grow the MTP Sector.

Orin is a member of ARCS, ASCEPT, DIA, RAPS, TOPRA, AGRE and HERDSA. 

Current Teaching

Postgraduate: Pharmaceutical Medicine Program

https://med.unsw.edu.au/pharmaceutical-medicine 

Undergraduate: Drug Discovery, Design and Development

Past teaching

Personalised Medicine MOOC

https://www.futurelearn.com/courses/personalised-medicine  

https://www.coursera.org/course/personalisedmed 

Current Research Interests

1.  Regulatory science and Pharmaceutical Medicine

2. Pharmaceutical Policy

3.  The scholarship of learning and teaching in pharmaceutical medicine, personalised medicine and cancer therapeutics

Students interested in ILP, Honours, DrPH or PhD projects in these areas, please contact Orin directly to discuss.

Journal Reviewer

Therapeutic Innovation and Regulatory Science 2017-present

Frontiers in Pharmacology - Pharmaceutical Medicine and Outcomes Research 2019-present

Frontiers in Medical Technology-Regulatory Affairs 2019-present

International/National Presentations

2020: Responding to COVID-19: how vaccines and medicines are developed and the impact of timeframes working under a pandemic. BRIDGE webinar series.

2018: Pfeiffer J; Naraynassamy C; Chisholm O.  Experiences of developing a PLuS Alliance course: pharmaceutical global regulatory affairs leadership, presented at King's Online & PLuS Alliance Conference, London, UK

2015: Online Training for Medical Affairs Professionals in China, presented at The China Medical Affairs Summit, Shanghai, China

International Education Programs 

2017: Pharmaceutical Medicine Training Program for delegation of pharmacists from Department of Health, Shandong Province, China

2015: Pharmaceutical Medicine Training Program for Ministry of  Health officials and leading Pharmacology Professors from several universities in Kazakhstan

Committees 

International:

  • DIA Regional Advisory Committee-Australia/NZ (Chair), 2018-present
  • RAPS Editorial Advisory Committee, 2018-present

Australian:

  • Gene Technology Technical Advisory Committee, 2017-2020

Local/UNSW:

  • SOMS Teaching Committee 2012-present
  • MedTELT Committee 2012-2018
  • Medicine Faculty Education Committee 2015-present
  • Cancer Clinical Academic Group (SPHERE) 2018-present
  • TCRN 2025 Cancer Workforce and Capacity Building Flagship 2017-present


My Grants

Australian

Member of Australia-wide CRITERIA (Clinical-Research-Industry’s-Talent-Expansion-Retention-Investment & Advancement) Consortium, led by ARCS Ltd, $250,000 funding received from MTPConnect for  Building clinical trial capability and capacity to grow the MTP Sector.

UNSW

Member of SEIF grant for “UNSW Micro-Credentialing Ecosystem for Recognising Learning and Skills Attainment in Capstone Courses and Internships” ($170,000).

Member of Education-focussed foundation funding grant for “Infrastructure enabling design, implementation and evaluation of innovations, ensuring excellence in student learning and experience” ($123,000).


My Qualifications

BSc (Hons) (USyd), GCULT (UNSW), PhD (USyd)


My Awards

2016: Faculty of Medicine teaching award for outstanding contributions to student learning.

2017: The Organisation for Professionals in Regulatory Affairs (TOPRA) Award for Regulatory Excellence in Education (international award).


My Research Activities

Regulatory Science

Pharmaceutical Medicine

Pharmaceutical Medicine Education


My Research Supervision


Supervision keywords


Areas of supervision

ILP, Honours, Masters, PhD, DrPH

Regulatory Science, Pharmaceutical Medicine, Pharmaceutical Medicine Education, Medical Education


Currently supervising

Mr Matthew Britland - Professional Doctorate in Public Health (DrPH); co-supervisors are A/P Anita Heywood and Dr Lois Meyer, SPHCM. Project: The role of the medical science liaison in contributing to the Quality Use of Medicines in Australia.

Ms Alina Yoffe - Masters by Research; joint supervisor Dr Greg Smith, co-supervisor Dr Johnson Liu. Project: Analysis of the impact of the new accelerated regulatory approval pathways on access to new medicines in Australia.

Completed students

Ms Eesha Bhargava - Honours student in Bachelor of Advanced Science and Arts program. Project: Innovative education in personalised medicine: analysis of engagement in a massive open online course.


My Engagement

MJA articleAustralia's National Medicines Policy is outdated and in need of review. Brendan Shaw and Orin Chisholm. Med J Aust || doi: 10.5694/mja2.50268 . Published online: 22 July 2019

Altmetrics score: 32 (In the top 5% of all research outputs scored by Altmetric)

MJA podcast

ABC radio AM

ABC Radio National Health Report

 

View less